DEXMEDETOMIDINE EVER PHARMA dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

dexmedetomidine ever pharma dexmedetomidine (as hydrochloride) 200 microgram/2 ml concentrated injection ampoule

interpharma pty ltd - dexmedetomidine hydrochloride, quantity: 236.4 microgram (equivalent: dexmedetomidine, qty 200 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - icu sedation.,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine ever pharma by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Ionolyte sodium chloride, sodium acetate trihydrate, potassium chloride, magnesium chloride, Injection for intravenous infusion 1000 mL Freeflex bag Australia - English - Department of Health (Therapeutic Goods Administration)

ionolyte sodium chloride, sodium acetate trihydrate, potassium chloride, magnesium chloride, injection for intravenous infusion 1000 ml freeflex bag

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

Ionolyte sodium chloride, sodium acetate trihydrate, potassium chloride, magnesium chloride, Injection for intravenous infusion 500 mL Freeflex bag Australia - English - Department of Health (Therapeutic Goods Administration)

ionolyte sodium chloride, sodium acetate trihydrate, potassium chloride, magnesium chloride, injection for intravenous infusion 500 ml freeflex bag

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

DEXMEDETOMIDINE FRESENIUS dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dexmedetomidine fresenius dexmedetomidine (as hydrochloride) 200 microgram/2 ml concentrated injection vial

fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 236 microgram (equivalent: dexmedetomidine, qty microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine fresenius by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

POTASSIUM CHLORIDE 20 mmol in SODIUM CHLORIDE 0.9% 500 mL injection for intravenous infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride 20 mmol in sodium chloride 0.9% 500 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 3 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 10 mmol in SODIUM CHLORIDE 0.9% 500 mL injection for intravenous infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride 10 mmol in sodium chloride 0.9% 500 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 20 mmol in SODIUM CHLORIDE 0.9% 1000 mL injection for intravenous infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride 20 mmol in sodium chloride 0.9% 1000 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - sodium chloride, quantity: 9 g/l; potassium chloride, quantity: 1.5 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 40 mmol in SODIUM CHLORIDE 0.9% 1000 mL injection for intravenous infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride 40 mmol in sodium chloride 0.9% 1000 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 3 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

DEXMEDETOMIDINE-TEVA dexmedetomidine (as HCl) 200 micrograms/2mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dexmedetomidine-teva dexmedetomidine (as hcl) 200 micrograms/2ml concentrated injection vial

teva pharma australia pty ltd - dexmedetomidine hydrochloride, quantity: 236 microgram (equivalent: dexmedetomidine, qty 200 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - icu sedation,for sedation of initially intubated patients during treatment in an intensive care setting.,the use of dexmedetomidine by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.